搜索临床试验以:比较器:HCTZ
总计2251个结果
-
University of Maryland, BaltimoreNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)完全的
-
Centers for Disease Control and PreventionUniversity of Illinois at Chicago; Howard Brown Health Center; Chicago Department of Public Health 和其他合作者完全的
-
University of North Carolina, Chapel HillUnited States Department of Defense完全的
-
University of NebraskaUniversity of Nebraska招聘中
-
H. Lee Moffitt Cancer Center and Research InstituteCelgene Corporation完全的
-
Bristol-Myers SquibbSanofi完全的
-
University of Maryland, BaltimoreKing Pharmaceuticals is now a wholly owned subsidiary of Pfizer终止
-
Boehringer Ingelheim完全的
-
Novartis PharmaceuticalsBaker Heart and Diabetes Institute完全的
-
Masonic Cancer Center, University of MinnesotaMinnesota Medical Foundation终止
-
Merck Sharp & Dohme LLCPfizer完全的
-
Roswell Park Cancer InstituteCelgene撤销复发性急性髓性白血病 | 难治性急性髓性白血病 | IDH2基因突变 | 原始细胞低于 5% 的外周血白细胞 | 与治疗前水平相比,骨髓原始细胞减少了 50% 或更多美国
-
Teran, Enrique, MD, PhDJarrow Formulas Inc; Ecuadorian Foundation for Science and Technology - FUNDACYT; Universidad...完全的
-
Children's Hospital Los Angeles招聘中
-
Fondazione Policlinico Universitario Agostino Gemelli...完全的
-
Medical College of WisconsinUniversity of Wisconsin, Madison; Amgen招聘中
-
Actinium Pharmaceuticals主动,不招人急性髓性白血病 | 白血病,骨髓,急性 | 反洗钱 | 急性髓性白血病 | 骨髓移植 | 骨髓性白血病,急性 | 髓样白血病,急性 | 白血病,急性骨髓性 | 白血病,急性髓系美国, 加拿大
-
Massachusetts General HospitalNational Institute of Neurological Disorders and Stroke (NINDS); University of Rochester终止
-
Boehringer Ingelheim完全的